Showing results (201-210 of 372) with videos related to
Sort By:
Pageof 38
Annals of Surgical Oncology|June 23, 2000
TA90-IC, a new marker for advanced colon cancerN Habal, R K Gupta, A J Bilchik, et al.The Journal of Investigative Dermatology|February 16, 1999
IgM anti-ganglioside antibodies induced by melanoma cell vaccine correlate with survival of melanoma patientsT Takahashi, T D Johnson, Y Nishinaka, et al.Annals of Surgical Oncology|November 27, 1998
Enhancement of complement-dependent cytotoxicity by polyvalent melanoma cell vaccine (CancerVax): correlation with survivalE C Hsueh, E Famatiga, R K Gupta, et al.The Journal of Urology|December 1, 1993
Aberrant expression of gangliosides in human renal cell carcinomasD S Hoon, E Okun, H Neuwirth, et al.Cancer Immunology, Immunotherapy : CII|November 1, 1993
Interleukin-4 plus tumor necrosis factor alpha augments the antigenicity of melanoma cellsD S Hoon, Y Hayashi, T Morisaki, et al.Cancer|January 1, 1976
Regional lymph node metastases and the level of invasion of primary melanomaE C Holmes, W Clark, D L Morton, et al.Cancer Treatment Reports|November 1, 1979
Cis-dichlorodiammineplatinum(II) alone and combined with DTIC for treatment of disseminated malignant melanomaJ E Goodnight, H S Moseley, F R Eilber, et al.Journal of Surgical Oncology|March 1, 1987
Tumor stabilization after hyperthermia: an important criterion of response to thermal therapyF K Storm, E F Scanlon, H W Baker, et al.Cancer Research|September 1, 1990
Suppressor cell activity in a randomized trial of patients receiving active specific immunotherapy with melanoma cell vaccine and low dosages of cyclophosphamideD S Hoon, L J Foshag, A S Nizze, et al.Cancer|November 1, 1975
Successful transurethral intralesional BCG therapy of a bladder melanomaJ B deKernion, S H Golub, R K Gupta, et al.Pageof 38